-

Babson Diagnostics Partners with ELLKAY to Simplify Clinician Orders of BetterWay™ Blood Testing

Clinicians will be able to easily order BetterWay using ELLKAY’s secure, cloud-based solution

AUSTIN, Texas--(BUSINESS WIRE)--Babson Diagnostics, a science-first healthcare technology company, today announced that it will use ELLKAY’s leading lab-ordering solution to make it easy for clinicians to order BetterWay™ blood testing. The partnership marks a significant milestone in Babson’s commitment to support clinicians in delivering a better patient experience and improving adherence to essential testing.

Since 2002, ELLKAY has been the leading laboratory partner for ordering and results interfaces, clinical data access, electronic health record integration, and more. ELLKAY’s clinician portal, known as LKCareEvolve, is an integrated ordering solution that directly connects with electronic health record platforms. Clinicians can now use the secure portal to order Babson’s new BetterWay blood testing service and receive test results.

“We are excited to partner with ELLKAY, which brings a wealth of expertise that perfectly complements Babson’s mission to reimagine blood testing,” said Tony Jones, vice president of clinician relations at Babson Diagnostics. “We know that many patients skip important testing due to fear, discomfort and difficult veins. With BetterWay we are now giving clinicians a medically equivalent alternative to traditional blood testing methods to offer their patients.”

BetterWay makes blood testing easier and more accessible by using only a pea-sized amount of blood to produce medically accurate results clinicians and patients can trust. BetterWay unites Babson’s proprietary automated sample-handling and analytical technologies with a novel blood collection device developed in partnership with BD (Beckton, Dickinson and Co.). The BD MiniDraw™ Capillary Blood Collection System is less invasive than a traditional blood draw, obtaining blood samples from the tip of the finger without the need for a phlebotomist to draw tubes of blood from a vein.

BetterWay’s innovations expand access to diagnostic testing to more convenient locations, such as retail pharmacies. The BetterWay test menu was created specifically to support primary care and family medicine, offering commonly ordered tests for annual wellness exams, chronic condition management, and screenings.

“We place a strong emphasis on innovation, connectivity solutions, efficiency, and addressing intricate interoperability challenges,” said Ajay Kapare, ELLKAY’s president and chief strategy officer. “When combined with Babson’s dedication to enhancing health and the patient’s full care journey, this partnership promises to have a significant impact.”

By integrating with CareEvolve, Babson offers clinicians a simple, familiar process for computerized order entry and secure access to test results that is compatible with smartphones and tablets. As part of the launch of BetterWay in Texas, Babson is partnering with medical practices in Austin and San Antonio to deliver a better testing experience that can help patients adhere to their routine blood testing more easily.

About Babson Diagnostics

Babson Diagnostics is a science-first healthcare technology company reimagining the entire diagnostic blood testing experience. Babson's mission is to make routine blood testing less invasive, more convenient, and affordable, empowering people to take charge of their health. Based in Austin, Babson is led by individuals with deep experience in healthcare, diagnostics, engineering, and laboratory technologies. The company is named in honor of Art Babson, whose legacy of scientific innovation and excellence is the foundation on which the company is built. For more information, visit babsondx.com.

About ELLKAY

ELLKAY is a recognized healthcare connectivity leader, providing interoperability solutions and services nationwide since 2002. ELLKAY empowers diagnostic laboratories, hospitals and health systems, healthcare IT vendors, payers, and other healthcare organizations with cutting-edge technologies and solutions. With over 58,000 practices connected, ELLKAY’s system capability arsenal has grown to over 750+ EHR/PM systems across 1,100+ versions. Visit ELLKAY.com and follow on YouTube, LinkedIn, X/Twitter, or email us at TeamELLKAY@ELLKAY.com

Contacts

Media inquiries only:
Joe Foster
BabsonDX@finnpartners.com
323-572-5361

For general inquiries: media@babsondx.com

Babson Diagnostics


Release Versions

Contacts

Media inquiries only:
Joe Foster
BabsonDX@finnpartners.com
323-572-5361

For general inquiries: media@babsondx.com

Social Media Profiles
More News From Babson Diagnostics

Babson Diagnostics Launches BetterWay Across Austin

AUSTIN, Texas--(BUSINESS WIRE)--Babson Diagnostics, a science-first healthcare technology company, is excited and proud to announce the launch of its groundbreaking blood testing service. BetterWay blood testing represents a significant advancement in an essential medical service, providing a patient-preferred experience and enabling high-quality testing in more convenient settings. Blood testing is the best way to monitor and manage health and makes up 70% of a patient’s medical chart. In the...

Babson Diagnostics Recognized for Achieving Highest Standards of Quality and Patient Safety for Laboratory Medicine

AUSTIN, Texas--(BUSINESS WIRE)--Babson Diagnostics, a science-first health care technology company, today announced its new, highly automated microsample laboratory has been awarded accreditation by the College of American Pathologists (CAP) based on the results of a recent on-site inspection. The global recognition is a critical step on Babson’s path to commercially launch the BetterWay™ blood testing service at retail pharmacies in Texas this year. BetterWay makes blood testing easier and mor...

Babson Diagnostics’ BetterWay™ Blood Testing Service Achieves Critical Milestone Ahead of Commercialization

AUSTIN, Texas--(BUSINESS WIRE)--Babson Diagnostics™, a science-first, health care technology company, today announced that a key piece of its BetterWay™ Blood Testing ecosystem has achieved 510(k) clearance from the U.S. Food and Drug Administration. These regulatory clearances pave the way for Babson to bring BetterWay—a first-of-its-kind blood testing service—to market next year. BetterWay will reimagine the entire blood testing process, using only a pea-sized amount of blood collected from a...
Back to Newsroom
  1. There was an issue with the authorization server. Please contact support if the issue persists.